Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's Disease

Fermé, Christophe; Eghbali, Houchingue; Meerwaldt, J.H.; Rieux, Chantal; Bosq, Jacques; Berger, Françoise; Girinsky, T.; Brice, Pauline; B. vanʼt Veer, Mars; Walewski, Jan; Lederlin, P; Tirelli, Umberto; Carde, Patrice; Van Den Neste, Éric; Gyan, Emmanuel; Monconduit, M.; Diviné, Marine; Raemaekers, John; Salles, Gilles; M. Noordijk, Evert; Creemers, Geert-Jan; Gabarre, Jean; Hagenbeek, Anton; Reman, Oumédaly; Blanc, Michel; Thomas, José; Vié, Brigitte; C. Kluin-Nelemans, Johanna; Viseu, Fernando; W. Baars, Joke; Poortmans, Philip; J. Lugtenburg, Pieternella; Carrié, C.; Jaubert, J.; Henry‐Amar, M.

doi:10.1056/nejmoa064601

Public

Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's Disease

Published in New England Journal of Medicine • Nov 7, 2007

Authors:

Christophe Fermé

Houchingue Eghbali

J.H. Meerwaldt

Abstract

BACKGROUND: Treatment of early-stage Hodgkin's disease is usually tailored in line with prognostic factors that allow for reductions in the amount of chemotherapy and extent of radiotherapy required for a possible cure. METHODS: From 1993 to 1999, we identified 1538 patients (age, 15 to 70 years) wh...

Subject

Medicine

Radiation therapy

Stage (stratigraphy)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!